Author

E. Adem

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Research Focus:cell type annotation· 3 Assay:flow cytometry· 3 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Assay:clinical cohort / trial· 1 Assay:proteomics· 1

Frequent Co-Authors

P. Kropf· 4 shared Y. Takele· 4 shared I. Muller· 3 shared E. Yizengaw· 2 shared J. A. Cotton· 2 shared M. Kaforou· 2 shared M. Levin· 2 shared R. Womersley· 2 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

P. Kropf

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Distinct neutrophil effector functions in response to different isolates of Leishmania aethiopica

E. Adem, E. Cruz Cervera, E. Yizengaw, Y. Takele, S. Shorter, J. Cotton, G. Getti, P. Kropf

The paper investigates how different Leishmania aethiopica isolates affect neutrophil effector functions in vitro, finding that long-term cultured isolates induce more ROS production and distinct neutrophil populations.

bioRxiv · Jun 27, 2024 · PreprintImmunology

Altered co-stimulatory and inhibitory receptors on monocyte subsets in patients with visceral leishmaniasis

E. Adem, E. Yizengaw, T. Mulaw, E. Nibret, I. Muller, Y. Takele, P. Kropf

This study examines changes in co-stimulatory and inhibitory receptors on monocyte subsets in visceral leishmaniasis patients before and after treatment.

bioRxiv · Mar 18, 2024Immunology

Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation

Y. Takele, E. Adem, S. U. Franssen, R. Womersley, M. Kaforou, M. Levin, I. Muller, J. A. Cotton, P. Kropf

This study shows that PD1/PDL-1 inhibition increases IFN-γ production in VL patients, suggesting potential for immune checkpoint therapy.

bioRxiv · Nov 1, 2021Immunology

Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV

Y. Takele, T. Mulaw, E. Adem, C. J. Shaw, S. U. Franssen, R. Womersley, M. Kaforou, G. P. Taylor, M. Levin, I. Muller, J. A. Cotton, P. Kropf

The paper identifies three immunological markers that predict visceral leishmaniasis relapse in HIV co-infected patients, showing they are more predictive than clinical features.

bioRxiv · Mar 30, 2021Immunology